At CoMo Compounding, we provide the highest quality sterile compounding for human and veterinary use.
Sterile compounding requires proper facilities and rigorous testing to ensure safety and accuracy. Our state-of-the-art facility utilizes ISO Class 7 buffer areas, ISO Class 5 primary engineering controls (PEC), and complies with all United States Pharmacopeia (USP) compounding standards, including USP <800>. Testing of our facilities and preparations are done by third parties to remove any conflict of interest. Initial and continuous personnel training is required, and evaluation of competencies is performed biannually.
Categories of sterile compounds at our facility include:
- Injectables
- Ophthalmics
- Irrigations
- Inhalation solutions
“Tri-Mix” Injection for Erectile Dysfunction
Men with erectile dysfunction (ED) who used triple therapy (papaverine/phentolamine/prostaglandin-E1) by intracavernosal injection (ICI) and then changed to oral sildenafil found they had a greater preference than expected for triple therapy. Overall, the erection quality with ICI was better than that with sildenafil.
- Fear of pain with intracavernosal injection (ICI) therapy may discourage its use. Yet, findings from a Cleveland Clinic study show that in the majority of ED patients, discomfort is minimal.
- Treatment with self-injections of vasoactive drugs in men with diabetes (both type 1 and type 2) and severe ED is a safe and effective alternative in the long term. The key is adjustment of the therapeutic method and dosage to optimal levels for satisfactory erections.
- Early intracavernosal injections following radical prostatectomy facilitated early sexual intercourse, patient satisfaction and potentially earlier return of natural erections, according to a study from the Glickman Urological Institute, Cleveland Clinic Foundation. Early combination therapy with sildenafil allowed a lower dose of intracavernous injections, minimizing the penile discomfort.
- A higher percentage of positive response in patients with erectile dysfunction was achieved with the trimix modality. Choice of more potent ICI regimens can improve efficacy.
BJU Int. 2003 Aug;92(3):277-80
Preference for oral sildenafil or intracavernosal injection in patients with erectile dysfunction already using intracavernosal injection for > 1 year.
Click here to access the PubMed abstract of this article.
J Sex Med. 2005 May;2(3):428-31.
Use of a visual analog scale to assess pain of injection with intracavernous injection therapy.
Click here to access the PubMed abstract of this article.
Asian J Androl. 2006 Mar;8(2):219-24.
Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
Click here to access the PubMed abstract of this article.
Int J Impot Res. 2006 Sep-Oct;18(5):446-51. Epub 2006 Feb 16.
Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections.
Click here to access the PubMed abstract of this article.
Arch Esp Urol. 2001 May;54(4):355-9.
[Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction]
Click here to access the PubMed abstract of this article.
Compounding Content © 2005-2021, Storey Marketing. All rights reserved.
